DNLI Overview
Upcoming Projects (DNLI)
-
Assessing Topline Results for DNL343 in ALS from the Phase 2/3 HEALEY ALS Platform Trial by Denali Therapeutics
Ticker: DNLI
Execute By: Jun 30, 2025
Executed Projects (DNLI)
-
Discussing investigational therapies for the treatment of Hunter Syndrome, including DNL310 and RGX-121
Tickers: DNLI, RGNX
Executed On: Oct 04, 2024 at 04:00 PM EDT
Upcoming & Overdue Catalysts (DNLI)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (DNLI)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
